VEGFA and central nervous system disorder: The dual effect of VEGF limits the use of either pro- or anti-VEGF strategies (e.g., anti-VEGF monoclonal antibodies/small molecule VEGFR inhibitors and mesenchymal stem cells engineered to produce VEGFA, respectively) in the treatment of CNS disorders (reviewed by Shim and Madsen, 2018).